The best of times, the worst of times for psychiatric disease

Nat Neurosci. 2012 May 25;15(6):811-2. doi: 10.1038/nn.3115.


As long-awaited advances in psychiatric genetics begin to materialize in force, promising to steer us safely to the best of times in psychiatric disease research, many pharmaceutical companies pull away from the challenge of drug development, threatening to bring us to the worst of times for the field. There is a real danger of missed opportunities and a sense of urgency for defining a clear path forward.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Drug Industry*
  • Humans
  • Mental Disorders / drug therapy*
  • Mental Disorders / genetics*
  • Psychiatry / trends*
  • Research Design